FUNDRAISING ROUNDUP | PA-18 | SC-5 | NY-19 | CA-50 | WV-1 | WI-6 | VA-7 | VA-5 | TX-31 | TX-23 | TN-4 | SC-1 | PA-17 | PA-11 | PA-10 | PA-1 | OH-14 | OH-10 | OH-7 | OH-1 | NY-22 | NY-11 | NC-13 | NC-9 | NJ-7 | NJ-3 | MN-2 | MI-8 | MI-7 | MI-6 | MI-1 | KY-6 | IN-9 | IL-14 | IL-12 | IA-4 | IA-1 | GA-7 | CA-48 | CA-25 | CA-8 | CA-4 | CA-1 | AR-2 | AK-0

More Than 40 GOP Incumbents Outraised in Q1

And at least 15 Republicans trailed a Democratic opponent in cash on hand.

Ally Mutnick
Add to Briefcase
Ally Mutnick
April 16, 2018, 11:14 a.m.

First-quarter fundraising reports were due Sunday night for the period ranging from Jan. 1 to March 31. Hotline found more than 40 incumbents who were outraised by one or more Democratic or independent challengers. (Note that some of the Pennsylvania members who were outraised found themselves in competitive districts, with new challengers, in mid-February—halfway through the quarter—thanks to court-ordered redistricting.)

The list:

Don Young (ALASKA AT-LARGE)
French Hill (AR-02)
Doug LaMalfa (CA-01)
Tom McClintock (CA-04)
Paul Cook (CA-08)
Steve Knight (CA-25)
Dana Rohrabacher (CA-48)
Rob Woodall (GA-07)
Mike Bost (IL-12)
Randy Hultgren (IL-14)
Trey Hollingsworth (IN-09)
Rod Blum (IA-01)
Steve King (IA-04)
Andy Barr (KY-06)
Jack Bergman (MI-01)
Fred Upton (MI-06)
Tim Walberg (MI-07)
Mike Bishop (MI-08)
Jason Lewis (MN-02)
Tom MacArthur (NJ-03)
Leonard Lance (NJ-07)
Robert Pittenger (NC-09)
Ted Budd (NC-13)
Dan Donovan (NY-11)
Claudia Tenney (NY-22)
Steve Chabot (OH-01)
Bob Gibbs (OH-07)
Mike Turner (OH-10)
Dave Joyce (OH-14)
Brian Fitzpatrick (PA-01)
Scott Perry (PA-10)
Lloyd Smucker (PA-11)
Mike Kelly (PA-16)
Mark Sanford (SC-01)
Scott DesJarlais (TN-04)
Will Hurd (TX-23)
John Carter (TX-31)
Brian Babin (TX-36)
Tom Garrett (VA-05)
Dave Brat (VA-07)
David McKinley (WV-01)
Glenn Grothman (WI-01)

And the following 15 Republicans trailed at least one opponent in cash on hand: McClintock; Rohrabacher; King; Bergman; Bishop; Pittenger; Budd; Donovan; Tenney; Garrett; Grothman; and Reps. Duncan Hunter (CA-50); John Faso (NY-19); Ralph Norman (SC-05), and Keith Rothfus (PA-17)*. (Hotline reporting)

*Rothfus’s opponent, Rep. Conor Lamb (D-PA 18), outraised him as well, but most of Lamb’s fundraising was for a special election in a different district, and Lamb didn’t make it clear he would run in the new 17th District until mid-March.

What We're Following See More »
TWO YEARS BEFORE HE JOINED TRUMP CAMPAIGN
FBI Interviewed Manafort in 2013, 2014
6 hours ago
THE LATEST

"Former Trump campaign chairman Paul Manafort was interviewed by the FBI twice while he was working as a political consultant for a Ukrainian political party—several years before he was named a top adviser to Donald Trump, newly filed court documents revealed." His deputy Rick Gates was also interviewed in 2014. "The information raises fresh questions about how closely the Trump campaign vetted staff members and whether Manafort and Gates told officials about their interactions with the FBI."

Source:
“WHAT DO YOU NEED THIS FOR?”
Trump Gives Ronny Jackson an Out
8 hours ago
THE LATEST
CAN STILL BE BRIEFED
Sessions Will Not Recuse Himself from Cohen Investigation
9 hours ago
THE LATEST
DESIGNED TO THWART PATENT TROLLS
SCOTUS Upholds Patent Review Legislation
9 hours ago
THE DETAILS

"The U.S. Supreme Court on Tuesday upheld a new government process for challenging the validity of patents, cementing a method that technology companies have used to knock out patent protections for more than a thousand claimed inventions. The court, in a 7-2 ruling written by Justice Clarence Thomas, affirmed the constitutionality of the new process, created by Congress in 2011 to offer a quicker and cheaper process for challenging patents before the U.S. Patent and Trademark Office, instead of going to court."

Source:
HOUSE ENERGY AND COMMERCE MARKS UP BILL TOMORROW
Senate HELP Unanimously Passes Opioid Bill
10 hours ago
THE LATEST
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login